Authors:
Dworkin, MS
Williamson, J
Jones, JL
Kaplan, JE
Citation: Ms. Dworkin et al., Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: Impact on risk for infectious diseases, CLIN INF D, 33(3), 2001, pp. 393-398
Authors:
Dworkin, MS
Ward, JW
Hanson, DL
Jones, JL
Kaplan, JE
Citation: Ms. Dworkin et al., Pneumococcal disease among human immunodeficiency virus-infected persons: Incidence, risk factors, and impact of vaccination, CLIN INF D, 32(5), 2001, pp. 794-800
Authors:
Kaplan, JE
Hanson, DL
Jones, JL
Dworkin, MS
Citation: Je. Kaplan et al., Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents, AIDS, 15(14), 2001, pp. 1831-1836
Citation: Ca. Dykewicz et al., Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients - Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplation, BIOL BLOOD, 6(6A), 2000, pp. 659
Authors:
Cohn, DL
O'Brien, RJ
Geiter, LJ
Gordin, FM
Hershfield, E
Horsburgh, CR
Jereb, JA
Jordan, TJ
Kaplan, JE
Nolan, CM
Starke, JR
Taylor, Z
Villarino, ME
Binkin, NJ
Bock, NN
Castro, KG
Chaisson, RE
Comstock, RE
Dworkin, MS
El-Sadr, W
Fujiwara, PI
Glassroth, JC
Godfrey-Faussett, P
Goldberger, MJ
Hadler, JL
Hopewell, PC
Iseman, MD
Jacobs, RF
Land, MA
Lobato, MN
Menzies, RI
Migliori, GB
Miller, BI
Mwinga, A
Nardell, EA
Neaton, J
Qualls, NL
Reichman, LB
Rose, DN
Salpeter, SR
Sawert, H
Simone, PM
Snider, DE
Tsevat, J
Vernon, AA
Whalen, CC
Wilcosky, TC
Citation: Dl. Cohn et al., Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection, AM J R CRIT, 161(4), 2000, pp. S221-S247
Citation: H. Masur et al., Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S1-S4
Authors:
Kaplan, JE
Hanson, D
Dworkin, MS
Frederick, T
Bertolli, J
Lindegren, ML
Holmberg, S
Jones, JL
Citation: Je. Kaplan et al., Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy, CLIN INF D, 30, 2000, pp. S5-S14
Authors:
Kaplan, JE
Masur, H
Holmes, KK
Freedberg, KA
Holtgrave, D
Piscitelli, SC
Van Dyke, R
Watts, H
Citation: Je. Kaplan et al., An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons, CLIN INF D, 30, 2000, pp. S15-S28
Authors:
Masur, H
Kaplan, JE
Holmes, KK
Alston, BL
Ampel, N
Anderson, JR
Baker, AC
Barr, D
Bartlett, JG
Bennett, JE
Benson, CA
Bozzette, SA
Chaisson, RE
Crumpacker, CS
Currier, JS
Deyton, L
Drew, WL
Duncan, WR
Eisinger, RW
El-Sadr, W
Feinberg, J
Freedberg, KA
Furrer, H
Gnann, JW
Goldberger, MJ
Goldie, S
Goosby, EP
Gross, PA
Hafner, R
Havlir, D
Hooton, TM
Jabs, DA
Jacobson, MA
Janoff, E
Kitahata, M
Kovacs, JV
Leport, C
Levin, MJ
Lopez, JC
Marco, M
Mayers, DL
Melnick, DA
Mofenson, LM
Montaner, JSG
Moore, R
Neaton, J
Nelson, C
O'Neill, JF
Palefsky, J
Pau, A
Phair, JP
Piscitelli, S
Polis, MA
Quinn, TC
Reiss, P
Rimland, D
Sears, CL
Seeff, L
Sepkowitz, KA
Slama, TG
Sloand, EM
Spector, SA
Thomas, DL
Van Dyke, RB
Watts, DH
Wheat, LJ
Whitcup, SM
Williams, P
Wright, TC
Castro, KG
DeCock, KM
Dowell, SF
Dworkin, MS
Dykewicz, C
Ellerbrock, T
Hajjeh, R
Holmberg, S
Holtgrave, DR
Jaffe, HW
Jones, JL
Juranek, DD
Mast, E
Navin, T
Pellett, PE
Reeves, WC
Stewart, JA
Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Authors:
Chapman, LE
Green, TA
Ahmed, F
Parekh, BS
Rimland, D
Kaplan, JE
Thompson, MA
Folks, TM
Citation: Le. Chapman et al., Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+T-lymphocyte counts of more than 500 x 10(6) cells/l, AIDS, 14(9), 2000, pp. 1135-1146
Authors:
Dworkin, MS
Hanson, DL
Kaplan, JE
Jones, JL
Ward, JW
Citation: Ms. Dworkin et al., Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4(+) T lymphocyte counts above prophylaxis thresholds, J INFEC DIS, 182(2), 2000, pp. 611-615
Authors:
Navin, TR
Rimland, D
Lennox, JL
Jernigan, J
Cetron, M
Hightower, A
Roberts, JM
Kaplan, JE
Citation: Tr. Navin et al., Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus, J INFEC DIS, 181(1), 2000, pp. 158-164
Authors:
Kaplan, JE
Parham, DL
Soto-Torres, L
van Dyck, K
Greaves, JA
Rauch, K
Ellis, B
Amandus, HE
Citation: Je. Kaplan et al., Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States, J ACQ IMM D, 21(3), 1999, pp. 228-235
Citation: Je. Kaplan et al., Do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease? Editorial response, CLIN INF D, 29(3), 1999, pp. 544-546
Authors:
Maloney, EM
Armien, B
Gracia, F
Castillo, L
Kruger, H
Levin, A
Levine, PH
Kaplan, JE
Blattner, WA
Giusti, RM
Citation: Em. Maloney et al., Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama, J INFEC DIS, 180(3), 1999, pp. 876-879
Authors:
Masur, H
Kaplan, JE
Holmes, KK
Alston, BL
Ampel, N
Anderson, JR
Baker, AC
Barr, D
Bartlett, JG
Bennett, JE
Benson, CA
Bozzette, SA
Chaisson, RE
Crumpacker, CS
Currier, JS
Deyton, L
Drew, WL
Duncan, WR
Eisinger, RW
El-Sadr, W
Feinberg, J
Freedberg, KA
Furrer, H
Gnann, JW
Goldberger, MJ
Goldie, S
Goosby, EP
Gross, PA
Hafner, R
Havlir, D
Hooton, TM
Jabs, DA
Jacobson, MA
Janoff, E
Kitahata, M
Kovacs, JV
Leport, C
Levin, MJ
Lopez, JC
Marco, M
Mayers, DL
Melnick, DA
Mofenson, LM
Montaner, JSG
Moore, R
Neaton, J
Nelson, C
O'Neill, JF
Palefsky, J
Pau, A
Phair, JP
Piscitelli, S
Polis, MA
Quinn, TC
Reiss, P
Rimland, D
Sears, CL
Seeff, L
Sepkowitz, KA
Slama, TG
Sloand, EM
Spector, SA
Thomas, DL
Van Dyke, RB
Watts, DH
Wheat, LJ
Whitcup, SM
Williams, P
Wright, TC
Castro, KG
DeCock, KM
Dowell, SF
Dworkin, MS
Dykewicz, C
Ellerbrock, T
Hajjeh, R
Holmberg, S
Holtgrave, DR
Jaffe, HW
Jones, JL
Juranek, DD
Mast, E
Navin, T
Pellett, PE
Reeves, WC
Stewart, JA
Villarino, ME
Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908